McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021;85(1):46–55.

CAS  Article  Google Scholar 

Shay DK. Safety monitoring of the Janssen (Johnson & Johnson) COVID-19 vaccine—United States, March–April 2021. MMWR Morbidity and mortality weekly report. 2021;70.

Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New England Journal of Medicine. 2020.

Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020.

Català A, Muñoz-Santos C, Galván-Casas C, et al. Cutaneous reactions after SARS-COV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases. Br J Dermatol. 2022;186(1):142–52.

Article  Google Scholar 

Shimabukuro TT, Nguyen M, Martin D, et al. Safety monitoring in the vaccine adverse event reporting system (VAERS). Vaccine. 2015;33(36):4398–405.

Article  Google Scholar 

Moro PL, Woo EJ, Marquez P, et al. Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011–2019. Vaccine. 2020;38(37):5923–6.

Article  Google Scholar 

Woo EJ, Moro PL. Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: reports to the vaccine adverse event reporting system. Vaccine. 2021;39(13):1812–7.

CAS  Article  Google Scholar 

Krajewski P, Matusiak J. Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine. J Eur Acad Dermatol Venereol. 2021;35(10): e632.

CAS  PubMed  PubMed Central  Google Scholar 

Piccolo V, Russo T, Mazzatenta C, et al. COVID vaccine‐induced pustular psoriasis in patients with previous plaque type psoriasis. J Eur Acad Dermatol Venereol. 2022.

Perna D, Jones J, Schadt CR. Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine. JAAD Case Rep. 2021;17:1–3.

Article  Google Scholar 

Durmaz I, Turkmen D, Altunisik N, et al. Exacerbations of generalized pustular psoriasis, palmoplantar psoriasis, and psoriasis vulgaris after mRNA COVID‐19 vaccine: A report of three cases. Dermatologic Therapy.e15331.

Bostan E, Elmas L, Yel B, et al. Exacerbation of plaque psoriasis after inactivated and BNT162b2 mRNA COVID-19 vaccines: a report of two cases. Dermatol Ther. 2021. https://doi.org/10.1111/dth.15110.

Article  PubMed  PubMed Central  Google Scholar 

Sotiriou E, Tsentemeidou A, Bakirtzi K, et al. Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centre. J Eur Acad Dermatol Venereol. 2021. https://doi.org/10.1111/jdv.17582.

Article  PubMed  PubMed Central  Google Scholar 

Huang Y-W, Tsai T-F. Exacerbation of psoriasis following COVID-19 vaccination: report from a single center. Front Med. 2021;8:2768.

Google Scholar 

Musumeci ML, Caruso G, Trecarichi AC, et al. Safety of SARS-CoV-2 vaccines in psoriatic patients treated with biologics: a real life experience. Dermatol Ther. 2022;35(1): e15177.

CAS  Article  Google Scholar 

Pitlick MM, Joshi AY, Gonzalez-Estrada A, et al., editors. Delayed systemic urticarial reactions following mRNA COVID-19 vaccination. Allergy and Asthma Proceedings; 2022: OceanSide Publications, Inc.

Magen E, Yakov A, Green I, et al., editors. Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2. Allergy & Asthma Proceedings; 2022.

Ramos CL, Kelso JM. “COVID Arm”: very delayed large injection site reactions to mRNA COVID-19 vaccines. J Allergy Clin Immunol Pract. 2021;9(6):2480–1.

Article  Google Scholar 

Marcantonio‐Santa Cruz O, Vidal‐Navarro A, Pesqué D, et al. Pityriasis rosea developing after COVID‐19 vaccination. J Eur Acad Dermatol Venereol. 2021.

Piccolo V, Bassi A, Argenziano G, et al. BNT162b2 mRNA COVID‐19 vaccine‐induced chilblain‐like lesions reinforces the hypothesis of their relationship with SARS‐CoV‐2. J Eur Acad Dermatol Venereol. 2021.

Freeman EE, McMahon DE, Lipoff JB, et al. Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries. J Am Acad Dermatol. 2020;83(2):486–92.

CAS  Article  Google Scholar 

Freeman EE, McMahon DE, Lipoff JB, et al. The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020;83(4):1118–29.

CAS  Article  Google Scholar 

Galván Casas C, Catala A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71–7.

Article  Google Scholar 

McMahon DE, Kovarik CL, Damsky W, et al. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: a registry-based study. J Am Acad Dermatol. 2022;86(1):113–21.

CAS  Article  Google Scholar 

Woo EJ, Mba-Jonas A, Dimova RB, et al. Association of receipt of the Ad26. COV2. S COVID-19 vaccine with presumptive Guillain-Barré syndrome, February-July 2021. JAMA. 2021;326(16):1606–13.

CAS  Article  Google Scholar